Russell Investments Group Ltd. Grows Stake in Humana Inc. (NYSE:HUM)

Russell Investments Group Ltd. grew its holdings in shares of Humana Inc. (NYSE:HUM) by 43.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 454,072 shares of the insurance provider’s stock after purchasing an additional 137,039 shares during the period. Russell Investments Group Ltd. owned approximately 0.38% of Humana worth $115,210,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in HUM. Pinnacle Wealth Management Advisory Group LLC raised its stake in Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after buying an additional 37 shares during the last quarter. Atlas Brown Inc. boosted its stake in Humana by 0.6% in the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock worth $1,611,000 after purchasing an additional 38 shares in the last quarter. Mather Group LLC. boosted its stake in Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock worth $60,000 after purchasing an additional 41 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. increased its stake in Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after purchasing an additional 43 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM stock opened at $253.37 on Friday. The company has a market capitalization of $30.58 billion, a P/E ratio of 25.46, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The business’s 50 day moving average is $267.58 and its two-hundred day moving average is $271.85. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.40%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Analyst Ratings Changes

HUM has been the topic of a number of research analyst reports. Piper Sandler boosted their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Eighteen analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus price target of $280.17.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.